PETS
What one share of PetMed Express holds
Retail – Drug Stores and Proprietary Stores
PetMed Express, Inc. and subsidiaries, d/b/a PetMeds®, and as parent company of PetCareRx®, is a pioneer in pet healthcare, building a consumer-first digital platform in 1996 that transformed the way customers fulfill pet medications.
PetMed Express’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $7.98 |
|---|---|
| Profit | −$1.38 |
| Capex (buildings and equipment) | $0.19 |
| Free cash flow | −$1.31 |
| Dividends | $0.00 |
| Cash and investments | $0.60 |
| Book value | $1.06 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $12.23 | $1.17 | $0.52 | $1.80 | $0.76 | $4.55 |
| 2018 | $13.40 | $1.82 | $0.03 | $1.79 | $0.85 | $5.62 |
| 2019 | $13.83 | $1.84 | $0.03 | $2.17 | $1.06 | $6.51 |
| 2020 | $14.17 | $1.29 | $0.12 | $1.82 | $1.08 | $5.97 |
| 2021 | $15.09 | $1.19 | $0.12 | $1.87 | $1.12 | $6.16 |
| 2022 | $13.37 | $0.92 | $0.09 | $0.82 | $1.20 | $5.88 |
| 2023 | $12.17 | $0.25 | $0.26 | $1.11 | $1.20 | $5.22 |
| 2024 | $13.44 | −$0.37 | $0.22 | −$0.01 | $0.60 | $4.57 |
| 2025 | $11.02 | −$0.30 | $0.25 | −$0.02 | $0.00 | $4.12 |
| 2026 | $8.56 | −$2.74 | $0.22 | −$1.58 | $0.00 | $1.35 |